SCHEMBL3960635

SCHEMBL3960635

Cc1cccc2[nH]cc(C(=O)C(=O)O)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 2/20 0.49
▸ NPC1 O15118 1/20 0.46
▸ NR4A2 P43354 2/20 0.44
▸ CTNNB1 P35222 1/20 0.43
▸ WNT3A P56704 1/20 0.43
▸ BRPF1 P55201 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ PBRM1 Q86U86 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ GAA P10253 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ MAPT P10636 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ DNMT1 P26358 1/20 0.40
▸ RECQL P46063 1/20 0.40
▸ CASP6 P55212 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ MCL1 Q07820 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3721316 0.87 GPR84 (0.49) GPR84NPC1NR4A2CTNNB1WNT3A
SCHEMBL3995494 0.86 GPR84 (0.51) GPR84NPC1NR4A2CTNNB1WNT3A
SCHEMBL23538240 0.85 GPR84 (0.47) GPR84NPC1NR4A2CTNNB1WNT3A
SCHEMBL15356576 0.83 PBRM1 (0.56) GPR84NPC1NR4A2CTNNB1WNT3A
SCHEMBL18837110 0.83 NR4A2 (0.51) GPR84NPC1NR4A2CTNNB1WNT3A
SCHEMBL11795053 0.81 GPR84 (0.50) GPR84NPC1NR4A2CTNNB1WNT3A
SCHEMBL1558360 0.80 HTR2A (0.49) GPR84NR4A2ALDH1A1ATMGAA
SCHEMBL16791407 0.80 GPR84 (0.49) GPR84NPC1NR4A2CTNNB1WNT3A
SCHEMBL2309708 0.79 HSD17B10 (0.55) GPR84NPC1NR4A2CTNNB1WNT3A
SCHEMBL9937305 0.79 NR4A2 (0.70) GPR84NPC1NR4A2CTNNB1WNT3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544685-B2 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2009-06-09 — — US disclosed
CN-101243075-A Novel 2,3-dihydroindole compounds LUNDBECK & CO AS H (DK) 2008-08-13 — — CN disclosed
EP-1928860-A1 NOVEL 2,3-DIHYDROINDOLE COMPOUNDS H.Lundbeck A/S (DK) 2008-06-11 — — EP disclosed
WO-2007019867-A1 NOVEL 2,3-DIHYDROINDOLE COMPOUNDS H. LUNDBECK A/S (DK) 2007-02-22 — — WO disclosed
US-20070043058-A1 Novel 2,3-dihydroindole compounds H. LUNDBECK A/S (DK) 2007-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043058-A1 Novel 2,3-dihydroindole compounds HTR2C, HTR2A, HTR5A GPR84 95/4885NPC1 1063/4885NR4A2 256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback